Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
about
Stem cell sources for tooth regeneration: current status and future prospectsChallenges to the clinical application of pluripotent stem cells: towards genomic and functional stabilityThe WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cellsSwitching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologiesTargeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsDirect cell reprogramming is a stochastic process amenable to accelerationMetastable pluripotent states in NOD-mouse-derived ESCsTotipotency, pluripotency and nuclear reprogrammingGeneration of human induced pluripotent stem cells by direct delivery of reprogramming proteinsMoving towards effective therapeutic strategies for Neuronal Ceroid LipofuscinosisiPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR SystemCellular reprogramming in farm animals: an overview of iPSC generation in the mammalian farm animal speciesModeling Kidney Disease with iPS CellsHematopoietic stem cell expansion and generation: the ways to make a breakthroughAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsProspects and Challenges of Induced Pluripotent Stem Cells in Equine HealthAdvanced cell therapies: targeting, tracking and actuation of cells with magnetic particlesResearch on induced pluripotent stem cells and the application in ocular tissuesApplications of iPSCs in Cancer ResearchMesenchymal Stromal Cells Affect Disease Outcomes via Macrophage PolarizationNew approaches to the treatment of orphan genetic disorders: Mitigating molecular pathologies using chemicalsInduced pluripotent stem cell technology for dissecting the cancer epigenomeAdvancements in stem cells treatment of skeletal muscle wastingFetal globin gene repressors as drug targets for molecular therapies to treat the β-globinopathiesInduced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's diseaseStem cells: update and impact on craniofacial surgeryPluripotent stem cells in research and treatment of hemoglobinopathiesDedifferentiation and reprogramming: origins of cancer stem cellsPluripotent stem cells and gene therapyInduction of pluripotency by defined factorsImmunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectivesHematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapiesReprogramming cells with synthetic proteinsAdvances in cellular technology in the hematology field: What have we learned so far?Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineeringiPSCs and small molecules: a reciprocal effort towards better approaches for drug discoveryInduced pluripotent stem cells as a disease modeling and drug screening platformDisease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe applicationStem cell transplantation for motor neuron disease: current approaches and future perspectives
P2860
Q21129232-D136A580-4272-42D8-B849-448815CF6F26Q21183968-93C9CF86-C31F-4DA1-86DC-3BA5A5A582D8Q24321371-75C582DE-108A-4EE6-A5C9-068575E2F2C3Q24617141-62164D55-9EBC-4F56-9CE8-5DC465322B60Q24634829-2677C55E-F8F1-46ED-B95D-9CB298B9D697Q24644898-DFE6DE51-487D-4010-BB8F-254CB3FC1057Q24645721-31B9F10B-6CDB-472F-B302-8033B9E308C0Q24646675-2F30E6DB-5FD0-4EA9-9655-3BD80AA04472Q24653753-3754276E-921D-4736-9317-DE2D795D7162Q26753109-AE5D6D81-9881-4E19-996D-87E89BFBC384Q26765886-86F9E9BB-1A04-4C5E-A89B-091BD398205EQ26768505-BFA3D753-365A-4D4D-B1D8-530DCFF79EDEQ26770384-4E0D5A86-3D88-4AC9-BF71-8037562BF6E2Q26771763-10335B90-B4FB-4586-8294-8AE939A48C49Q26775122-7B3E46D7-638F-4B41-8CE7-E5F7F337DA47Q26776053-AE2A6351-0358-4042-81C8-CB5A95243551Q26782710-7DE5DD9E-853F-4BBC-8F34-9D7B5E83DFC5Q26796711-677F3410-9FCD-4D8E-B2B4-9FE88079BE02Q26798036-BDE7AD1C-8738-479F-A879-20996A772674Q26800098-2FA5EF44-4927-471B-9431-B46C92FBC9B3Q26801582-946BB3D6-A4C4-4BC2-9B05-68642765CAE0Q26801711-B760E009-E78B-4DDD-9A65-F9A415DF0A46Q26822437-22DEC0A9-CC6D-495B-BD78-D6C4F218CC07Q26822810-F21845D5-6D10-41A8-97FE-9BD9436F0923Q26823333-3B896889-8807-4005-B86E-8F5A867D74C0Q26824134-67196683-5DE3-43AB-AE8A-BFAA74D1AA98Q26825713-126752DE-F2C4-4B69-ACCC-F6696F549DDFQ26826876-4E2002A2-E283-48BF-8377-FDE45A14D61AQ26827643-5283902C-DA6B-415D-AF62-967E3F79F54EQ26830425-871A5213-E034-4E92-8E08-76E282E40360Q26849530-D57829F6-9BA4-4231-9EE5-E79490A86E06Q26851475-9E85C9D4-0226-4CAD-94CB-977F57068B62Q26851666-5FFC1F0E-1A1C-43F2-A60F-6FCD5CDAD663Q26853155-DEB7F982-B311-4D68-A300-D293CCDC087BQ26853179-3BA628E9-10E9-4884-8304-6C4631C773ECQ26863381-E752A976-CC8C-463E-86B1-ECA0EBB54BF8Q26865055-9F834C23-40D7-444B-BB3C-BA75AE6B71C2Q26865689-880E6273-2D48-45A7-A8F0-7263CB32540BQ26866409-9690F566-7F6D-4731-BAF0-03DEA810B061Q26995278-558540BE-64B2-4CCD-A03E-2B1F684AB97E
P2860
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
@ast
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
@en
type
label
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
@ast
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
@en
prefLabel
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
@ast
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
@en
P2093
P2860
P3181
P356
P1433
P1476
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
@en
P2093
Brambrink T
Cassady JP
Markoulaki S
Meissner A
P2860
P304
P3181
P356
10.1126/SCIENCE.1152092
P407
P577
2007-12-21T00:00:00Z